Definium Therapeutics annual current ratio
2020
2021
2022
2023
2024
2025
Definium Therapeutics Current Ratio Growth & History (DFTX)
Definium Therapeutics's current ratio was 6.29 for fiscal 2025.
View full Definium Therapeutics company overviewDefinium Therapeutics annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 6.29 | −0.96 | −13.27% |
| 2024 | 2024-12-31 | 7.25 | 4.03 | +125.04% |
| 2023 | 2023-12-31 | 3.22 | −4.94 | −60.54% |
| 2022 | 2022-12-31 | 8.16 | −5.02 | −38.08% |
| 2021 | 2021-12-31 | 13.18 | −13.92 | −51.35% |
| 2020 | 2020-12-31 | 27.10 | — | — |
Definium Therapeutics quarterly current ratio
Q4.20
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 6.95 | 1.96 | +39.42% |
| Q1 2026 | 2026-03-31 | 4.69 | −2.58 | −35.49% |
| Q4 2025 | 2025-12-31 | 6.29 | −0.96 | −13.27% |
| Q3 2025 | 2025-09-30 | 3.30 | −5.70 | −63.33% |
| Q2 2025 | 2025-06-30 | 4.98 | −0.94 | −15.82% |
| Q1 2025 | 2025-03-31 | 7.27 | 3.36 | +85.82% |
| Q4 2024 | 2024-12-31 | 7.25 | 4.03 | +125.04% |
| Q3 2024 | 2024-09-30 | 9.00 | 5.14 | +133.47% |
| Q2 2024 | 2024-06-30 | 5.92 | 2.51 | +73.54% |
| Q1 2024 | 2024-03-31 | 3.91 | −1.58 | −28.77% |
| Q4 2023 | 2023-12-31 | 3.22 | −4.94 | −60.54% |
| Q3 2023 | 2023-09-30 | 3.85 | −2.16 | −35.87% |
| Q2 2023 | 2023-06-30 | 3.41 | −10.45 | −75.39% |
| Q1 2023 | 2023-03-31 | 5.50 | −6.18 | −52.91% |
| Q4 2022 | 2022-12-31 | 8.16 | −5.02 | −38.08% |
| Q3 2022 | 2022-09-30 | 6.01 | — | — |
| Q2 2022 | 2022-06-30 | 13.86 | — | — |
| Q1 2022 | 2022-03-31 | 11.67 | — | — |
| Q4 2021 | 2021-12-31 | 13.18 | −13.92 | −51.35% |
| Q4 2020 | 2020-12-31 | 27.10 | — | — |
Definium Therapeutics current ratio trends
Over the last five fiscal years, Definium Therapeutics's current ratio decreased from 27.10 to 6.29, a change of −20.81. The latest reported quarter, Q2 2026, shows 6.95.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Definium Therapeutics source filings ↗